Glycogen synthase kinase 3β regulation of nuclear factor of activated T-cells isoform c1 in the vascular smooth muscle cell response to injury

Experimental Cell Research

Volumn 314, Issue 16, 2008, Pages 2919-2929

  Chow, Winsion ^a   Hou, Guangpei ^a   Bendeck, Michelle P ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Atherosclerosis; Glycogen synthase kinase 3 ; Migration; Nuclear factor of activated T cells; Proliferation; Smooth muscle cell

Indexed keywords

CYCLOSPORIN A; GLYCOGEN SYNTHASE KINASE 3BETA; MUTANT PROTEIN; NUCLEAR FACTOR OF ACTIVATED T CELLS C1; PHOSPHOPROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FRACTIONATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WOUND HEALING;

EID: 51749088321     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.07.010     Document Type: Article

References (39)

1. Hill-Eubanks D.C., Gomez M.F., Stevenson A.S., and Nelson M.T. NFAT regulation in smooth muscle. Trends in Cardiovascular Medicine 13 (2003) 56-62
2. Crabtree G.R., and Olson E.N. NFAT signaling: choreographing the social lives of cells. Cell 109 (2002) S67-S79
3. Hogan P.G., Chen L., Nardone J., and Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17 (2003) 2205-2232
4. Boss V., Abbott K.L., Wang X.F., Pavlath G.K., and Murphy T.J. The cyclosporin A-sensitive nuclear factor of activated T cells (NFAT) proteins are expressed in vascular smooth muscle cells. Differential localization of NFAT isoforms and induction of NFAT-mediated transcription by phospholipase C-coupled cell surface receptors. J. Biol. Chem. 273 (1998) 19664-19671
5. Yellaturu C.R., Ghosh S.K., Rao R.K., Jennings L.K., Hassid A., and Rao G.N. A potential role for nuclear factor of activated T-cells in receptor tyrosine kinase and G-protein-coupled receptor agonist-induced cell proliferation. Biochem. J. 368 (2002) 183-190
6. Suzuki E., Nishimatsu H., Satonaka H., Walsh K., Goto A., Omata M., Fujita T., Nagai R., and Hirata Y. Angiotensin II induces myocyte enhancer factor 2- and calcineurin/nuclear factor of activated T cell-dependent transcriptional activation in vascular myocytes. Circ. Res. 90 (2002) 1004-1011
7. Nilsson L.M., Sun Z.W., Nilsson J., Nordstrom I., Chen Y.W., Molkentin J.D., Wide-Swensson D., Hellstrand P., Lydrup M.L., and Gomez M.F. Novel blocker of NFAT activation inhibits interleukin-6 production in human myometrial arteries and reduces vascular smooth muscle cell proliferation. Am. J. Physiol. Cell Physiol. 292 (2007) 1167-1178
8. Lipskaia L., Pourci M.L., Delomenie C., Combettes L., Goudouneche D., Paul J.L., Capiod T., and Lompre A.M. Phosphatidylinositol 3-kinase and calcium-activated transcription pathways are required for VLDL-induced smooth muscle cell proliferation. Circ. Res. 92 (2003) 1115-1122
9. Gonzalez Bosc L.V., Wilkerson M.K., Bradley K.N., Eckman D.M., Hill-Eubanks D.C., and Nelson M.T. Intraluminal pressure is a stimulus for NFATc3 nuclear accumulation: role of calcium, endothelium derived nitric oxide, and cGMP-dependent protein kinase. J. Biol. Chem. 279 (2004) 10702-10709
10. Liu Z., Dronadula N., and Rao G.N. A novel role for nuclear factor of activated T cells in receptor tyrosine kinase and G protein-coupled receptor agonist-induced vascular smooth muscle cell motility. J. Biol. Chem. 279 (2004) 41218-41226
11. Yu H., Sliedregt K., Overkleef H., van der Marel G.A., van Berkel T.J.C., and Biessen E.A.L. Therapeutic potential of a synthetic peptide inhibitor of nuclear factor of activated T cells as antirestenotic agent. Arterioscler. Thromb. Vasc. Biol. (2006) 01
12. Liu Z., Zhang C., Dronadula N., Li Q., and Rao G.N. Blockade of nuclear factor of activated T cells activation signaling suppresses balloon injury-induced neointima formation in a rat carotid artery model. J. Biol. Chem. 280 (2005) 14700-14708
13. Donners M.M.P.C., Bot I., De Windt L.J., van Berkel T.J.C., Daemen M.J.A.P., Biessen E.A.L., and Heeneman S. Low-dose FK506 blocks collar-induced atherosclerotic plaque Development and stabilizes plaques in ApoE-/- mice. American Journal of Transplantation 5 (2005) 1204-1215
14. Beals C.R., Sheridan C.M., Turck C.W., Gardner P., and Crabtree G.R. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275 (1997) 1930-1933
15. Neal J.W., and Clipstone N.A. Glycogen synthase kinase-3 inhibits the DNA binding activity of NFATc. J. Biol. Chem. 276 (2001) 3666-3673
16. Park K.W., Yang H.M., Youn S.W., Yang H.J., Chae I.H., Oh B.H., Lee M.M., Park Y.B., Choi Y.S., Kim H.S., and Walsh K. Constitutively active glycogen synthase kinase-3{beta} gene transfer sustains apoptosis, inhibits proliferation of vascular smooth muscle cells, and reduces neointima formation after balloon injury in rats. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1364-1369
17. Macian F., Garcia-Rodriguez C., and Rao A. Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. EMBO J. 19 (2000) 4783-4795
18. Kim H.S., Skurk C., Thomas S.R., Bialik A., Suhara T., Kureishi Y., Birnbaum M., Keaney Jr. J.F., and Walsh K. Regulation of angiogenesis by glycogen synthase kinase-3beta. J. Biol. Chem. 277 (2002) 41888-41896
19. Chuvpilo S., Zimmer M., Kerstan A., Glockner J., Avots A., Escher C., Fischer C., Inashkina I., Jankevics E., and Berberich-Siebelt F. Alternative polyadenylation events contribute to the induction of NF-ATc in effector T cells. Immunity 10 (1999) 261-269
20. Chuvpilo S., Avots A., Berberich-Siebelt F., Glockner J., Fischer C., Kerstan A., Escher C., Inashkina I., Hlubek F., Jankevics E., Brabletz T., and Serfling E. Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes. J. Immunol. 162 (1999) 7294-7301
21. Houck J.C. Migration and proliferation of diploid human fibroblasts following "wounding" of confluent monolayers. Journal of Cellular Physiology 74 (1969) 235-243
22. Chuvpilo S., Jankevics E., Tyrsin D., Akimzhanov A., Moroz D., Jha M.K., Schulze-Luehrmann J., Santner-Nanan B., Feoktistova E., and Konig T. Autoregulation of NFATc1/A expression facilitates effector T cells to escape from rapid apoptosis. Immunity 16 (2002) 881-895
23. Asagiri M., Sato K., Usami T., Ochi S., Nishina H., Yoshida H., Morita I., Wagner E.F., Mak T.W., Serfling E., and Takayanagi H. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 202 (2005) 1261-1269
24. Zhou B., Wu B., Tompkins K.L., Boyer K.L., Grindley J.C., and Baldwin H.S. Characterization of Nfatc1 regulation identifies an enhancer required for gene expression that is specific to pro-valve endocardial cells in the developing heart. Development 132 (2005) 1137-1146
25. Zhou B., Cron R.Q., Wu B., Genin A., Wang Z., Liu S., Robson P., and Baldwin H.S. Regulation of the murine Nfatc1 gene by NFATc2. J. Biol. Chem. 277 (2002) 10704-10711
26. Scherberich A., Campos-Toimil M., Ronde P., Takeda K., and Beretz A. Migration of human vascular smooth muscle cells involves serum-dependent repeated cytosolic calcium transients. J. Cell Sci. 113 (2000) 653-662
27. i increase and its transcriptional activation of immediate early genes is important in the regulation of motility. Exp. Cell Res. 246 (1999) 319-326
28. Bonnet S., Rochefort G., Sutendra G., Archer S.L., Haromy A., Webster L., Hashimoto K., Bonnet S.N., and Michelakis E.D. The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 11418-11423
29. Neal J.W., and Clipstone N.A. A constitutively active NFATc1 mutant induces a transformed phenotype in 3T3-L1 fibroblasts. J. Biol. Chem. 278 (2003) 17246-17254
30. Buchholz M., Schatz A., Wagner M., Michl P., Linhart T., Adler G., Gress T.M., and Ellenrieder V. Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway. EMBO J. 25 (2006) 3714-3724
31. fonso-Jaume M.A., Mahimkar R., and Lovett D.H. Co-operative interactions between NFAT (nuclear factor of activated T cells) c1 and the zinc finger transcription factors Sp1/Sp3 and Egr-1 regulate MT1-MMP (membrane type 1 matrix metalloproteinase) transcription by glomerular mesangial cells. Biochem. J. 380 (2004) 735-747
32. Filippov S., Koenig G.C., Chun T.H., Hotary K.B., Ota I., Bugge T.H., Roberts J.D., Fay W.P., Birkedal-Hansen H., Holmbeck K., Sabeh F., Allen E.D., and Weiss S.J. MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells. J. Exp. Med. 202 (2005) 663-671
33. Ho B., Hou G., Pickering J.G., Hannigan G., Langille B.L., and Bendeck M.P. Integrin-linked kinase in the vascular smooth muscle cell response to injury. Am. J. Pathol. 173 (2008) 278-288
34. Nilsson J., Nilsson L.M., Chen Y.W., Molkentin J.D., Erlinge D., and Gomez M.F. High glucose activates nuclear factor of activated T cells in native vascular smooth muscle. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 794-800
35. Etienne-Manneville S., and Hall A. Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarity. Nature 421 (2003) 753-756
36. Doble B.W., and Woodgett J.R. GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116 (2003) 1175-1186
37. Sheridan C.M., Heist E.K., Beals C.R., Crabtree G.R., and Gardner P. Protein kinase A negatively modulates the nuclear accumulation of NF-ATc1 by priming for subsequent phosphorylation by glycogen synthase kinase-3. J. Biol. Chem. 277 (2002) 48664-48676
38. Palmer D., Tsoi K., and Maurice D.H. Synergistic inhibition of vascular smooth muscle cell migration by phosphodiesterase 3 and phosphodiesterase 4 inhibitors. Circ. Res. 82 (1998) 852-861
39. Indolfi C., Vittorio Avvedimento E., Lorenzo E.D., Esposito G., Rapacciuolo A., Giuliano P., Grieco D., Cavuto L., Stingone A.M., Ciullo I., Condorelli G., and Chiariello M. Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury. Nat. Med. 3 (1997) 775-779